Glial fibrillary acidic protein is one of the key factors underlying neuron-like elongation in PC12 cells

  • Authors:
    • Maki Sugaya-Fukasawa
    • Toru Watanabe
    • Michiko Tamura
    • Satsuki Egashira
    • Hisashi Hisatomi
  • View Affiliations

  • Published online on: November 5, 2010     https://doi.org/10.3892/etm.2010.162
  • Pages: 85-87
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Nerve growth factor (NGF) normally induces the differentiation of PC12 cells into a neuron-like phenotype. In this study, we found that exposure of PC12 cells to a temperature of 42˚C for 24 h significantly decreased NGF-induced neurite elongation. Glial fibrillary acidic protein (GFAP) levels were decreased when PC12 cells were exposed to the heat stress, while PC12 cells overexpressing the gene encoding GFAP showed resistance. Mock-transfected PC12 cells exposed to NGF could be cultured for 72 h at 37˚C, whereas GFAP-transfected PC12 cells exposed to NGF could be cultured for over 100 h. Our results suggest that GFAP is necessary for the long-term maintenance of cells with a neuron-like phenotype.

Introduction

Glial fibrillary acidic protein (GFAP) is expressed in astrocytes in the central nervous system (CNS) (1) and is involved in many cellular functioning processes, such as cell structure and movement, cell communication and the functioning of the blood-brain barrier (2,3). It was found that the levels of several proteins expressed in astrocytes are altered in an Alzheimer's disease model (4,5), and cleavage of GFAP may contribute to astrocyte injury and damage in the Alzheimer's disease brain (68). GFAP plays an important role in mitosis, directly or indirectly, by adjusting the filament network present in the cell. During mitosis, the amount of phosphorylated GFAP increases and moves to the cleavage furrow (9). In vitro, astrocytes treated with antisense RNA against GFAP do not form a neuron-like phenotype (10). There are multiple disorders associated with inactive GFAP regulation, and mutations in the coding region of the GFAP gene are associated with Alzheimer's disease (11). Therefore, GFAP is thought to play crucial roles in the development and differentiation of astrocytes and is believed to be involved in the long-term maintainance of normal CNS myelination (12). However, the mechanisms by which GFAP is involved in the development and differentiation of astrocytes are not yet completely understood. To better understand the effect of GFAP expression on neurons, we generated stable PC12 cell lines overexpressing this gene.

The PC12 cell line, which was derived from a pheochromocytoma of the rat adrenal medulla (13), is the most common cell line used as neuron-like cells with neuron-like elongation abilities. Maintenance of the neuronal phenotype and survival of differentiated PC12 cells under serum-free conditions require constant nerve growth factor (NGF) exposure. PC12 cells stop dividing and terminally differentiate when treated with NGF. In the present study, PC12 cells with neuron-like elongation underwent apoptosis within 70–80 h. However, the PC12 cells overexpressing pGFAP from the plasmid underwent cell death 120 h after NGF exposure. The overexpression of GFAP delayed cell death in the PC12 cells.

Materials and methods

Cell culture

The PC12 cell line was purchased from the Japan Health Science Foundation (HSRRB, Osaka, Japan) and maintained in DMEM supplemented with heat-inactivated fetal bovine serum and horse serum. After culture for 48 h, the cells were treated with 1.0 μM NGF (Kyowa, Tokyo, Japan) for 0, 24, 48, 72, 96 or 120 h. All cells were grown in 5% CO2 at 37°C. The temperature was adjusted to 42°C, and cells were observed. Apoptosis was detected by Annexin V and propidium iodide (PI) staining using flow cytometry (Quanta SC, Beckman Coulter, Fullerton, CA, USA).

RT real-time PCR analysis

Total RNA was extracted from the PC12 cells using the QuickGene RNA Cultured Cell HC Kit S (Fujifilm, Kanagawa, Japan) following the manufacturer's instructions. The final RNA preparations were resuspended in diethylpyrocarbonate-treated water and quantified by absorbance analysis at 260 nm. cDNA was prepared by incubating DNase-treated total RNA (0.1 μg) with M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA) in the presence of random primers (Invitrogen). The real-time PCR reaction mixture was prepared using a FastStart SYBR Green Master (Roche Diagnostics, Mannheim, Germany). The primer set for amplification of a GFAP mRNA was designed according to GenBank NM_017009, using a forward primer at the exon 2 region, 5′-CAA GAT GAA ACC AAC CTG AGG CT-3′, and a reverse primer at the exon 4 region, 5′-GGC TTG GCC ACA TCC ATC T-3′ (product length 221 bp). The primer set for amplification of a myelin basic protein (MBP) mRNA was designed according to GenBank M25889, using a forward primer at the exon 4–6 region, 5′-GGC AAG GAC TCA CAC ACR AGA ACT-3′, and a reverse primer at the exon 7–8 region, 5′-GGG ACA GGC CTC TCC CCT T-3′ (product length 154 bp). The primer set for amplification of a class III β-tubulin mRNA was designed according to GenBank AF459021, using a forward primer at the exon 2 region, 5′-ATA GAC CCC AGC GGC AAC TAT GTG-3′, and a reverse primer at the exon 3 region, 5′-AGG CCT GAA TAG GTG TCC AAA GGC-3′ (product length 174 bp). The real-time PCR reaction was carried out for 45 cycles (95°C for 20 sec, 60°C for 30 sec and 72°C for 20 sec) using an iCycler iQ™ Real-Time Detection System (Bio-Rad, Hercules, CA, USA). GAPDH cDNA was amplified for normalization (Applied Biosystems, Foster City, CA, USA); mRNA levels are presented as the mRNA copy number per μg total RNA.

Overexpression of pGFAP

The gene encoding GFAP was subcloned into the mammalian expression vector pTriEX™-3 (Merck, San Diego, CA, USA), and the entire sequence was verified by DNA sequencing. For overexpression in PC12 cells, GFAP was subcloned from pTriEX™-3 vectors into NovaBlue Singles™ competent cells (Merck). The resultant plasmids were designated as pGFAP. Cells were seeded at a density of 106 cells per 10-cm dish and transfected with 8 μg of plasmid DNA using 120 μl of GeneJuice® Transfection reagent (Merck) for 2 h at 37°C, after which time the DMEM medium plus 10% serum was changed. After 24 h, cells were cultured under serum-free conditions and exposed to NGF stimulation. PC12 cells that were stably transfected with cDNAs encoding GFAP or the empty vector (mock) were grown to confluence in DMEM.

Results

RT real-time PCR

The levels of GFAP mRNA in the culture at 37°C ranged from 104.6 to 105.5 copies/μg total RNA and were evaluated as the mean ± SE (105.1±100.4) copies/μg total RNA. The levels of GFAP mRNA in the culture at 42°C ranged from 0.0 to 102.1 copies/μg total RNA and were evaluated as the mean ± SE (101.2±100.9) copies/μg total RNA; this difference was significant (p<0.01; Student's t-test). The levels of MBP mRNA in the culture at 37 and 42°C were 103.9–104.6 and 103.8–104.6 copies/μg total RNA, respectively. The levels of class III β-tubulin mRNA in the culture at 37 and 42°C were 104.7–105.6 and 104.9–105.3 copies/μg total RNA, respectively (Fig. 1).

Cell culture and overexpression of pGFAP

In the mock-transfected PC12 cells exposed to NGF, no apoptosis was induced at 0, 24 or 48 h at 37°C. After 72 h, apoptosis was induced when the cell that expands the neurite was cultured at 37°C (data not shown). Exposure of PC12 cells to a temperature of 42°C for 24 h significantly decreased NGF-induced neuron-like elongation compared to cells cultured at 37°C, while it was possible to maintain the neuron-like elongation at 42°C in the cells with pGFAP overexpression (Fig. 2). Mock-transfected PC12 cells showed similar features to control PC12 cells when incubated at 42°C. In cells overexpressing pGFAP, neuron-like elongation was maintained in the culture for 120 h (Fig. 3).

Discussion

In the present study, GFAP was found to play an important role, directly or indirectly, in the protection of in vitro PC12 cultured cells from damage. Unfortunately, apoptosis progresses rapidly and the relation between the level of GFAP and the degree of inhibition of apoptosis is not yet understood. However, it appears that the existence of GFAP inhibited apoptosis in the PC12 cells with neuron-like elongation. Heat stress at a temperature of 42°C caused the PC12 cells to die. Neuron-like elongation was lost in the cultures at 42°C, and these cells underwent apoptosis. Severe stress was found to play a role in the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease. If neuronal cells can be made sufficiently resistant to stress, then the pathogenesis of neuro-degenerative diseases should be slowed or decreased. Our results corroborate those of other researchers who have shown that GFAP is necessary for the long-term maintenance of the normal CNS (1416).

The mechanism by which GFAP overexpression inhibits the apoptosis of PC12 cells is uncertain. However, we propose that this novel function of GFAP plays an important role in the ability of astrocytes to protect neuronal cells against apoptosis. These data support the concept that GFAP is responsible for many of the progressive astroglial changes that appear after CNS injury and disease. Further evaluation of this and other possible roles of GFAP, as well as the regulation of GFAP expression, are crucially important for the development of new strategies for maintaining homeostasis in the nervous system.

References

1. 

Rodríguez JJ, Olabarria M, Chvatal A and Verkhratsky A: Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 16:378–385. 2009.

2. 

Bignami A, Eng LF, Dahl D and Uyeda CT: Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res. 43:429–435. 1972. View Article : Google Scholar : PubMed/NCBI

3. 

Antanitus DS, Choi BH and Lapham LW: Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein. Brain Res. 89:363–367. 1975. View Article : Google Scholar : PubMed/NCBI

4. 

Counts SE and Mufson EJ: The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J Neuropathol Exp Neurol. 64:263–272. 2005.PubMed/NCBI

5. 

Angelopoulos P, Agouridaki H, Vaiopoulos H, et al: Cytokines in Alzheimer's disease and vascular dementia. Int J Neurosci. 118:1659–1672. 2008.

6. 

Eng LF and Ghirnikar RS: GFAP and astrogliosis. Brain Pathol. 4:229–237. 1994. View Article : Google Scholar : PubMed/NCBI

7. 

Mouser PE, Head E, Ha KH and Rohn TT: Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am J Pathol. 168:936–946. 2006.PubMed/NCBI

8. 

Quinlan RA, Brenner M, Goldman JE and Messing A: GFAP and its role in Alexander disease. Exp Cell Res. 313:2077–2087. 2007. View Article : Google Scholar : PubMed/NCBI

9. 

Tardy M, Fages C, Le Prince G, Rolland B and Nunez J: Regulation of the glial fibrillary acidic protein (GFAP) and of its encoding mRNA in the developing brain and in cultured astrocytes. Adv Exp Med Biol. 265:41–52. 1990. View Article : Google Scholar : PubMed/NCBI

10. 

Lefrançois T, Fages C, Peschanski M and Tardy M: Neuritic outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein (GFAP) mRNA in injured neuron-astrocyte cocultures. J Neurosci. 17:4121–4128. 1997.

11. 

Brenner M, Johnson AB, Boespflug-Tanguy O, et al: Mutations in GFAP encoding glial fibrillary acidic protein are associated with Alexander disease. Nat Genet. 27:117–120. 2001. View Article : Google Scholar : PubMed/NCBI

12. 

Goss JR, Finch CE and Morgan DG: Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging. 12:165–170. 1991. View Article : Google Scholar : PubMed/NCBI

13. 

Greene LA and Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA. 73:2424–2428. 1976. View Article : Google Scholar

14. 

Pekny M, Levéen P, Pekna M, et al: Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 14:1590–1598. 1995.PubMed/NCBI

15. 

Shibuki K, Gomi H, Chen L, et al: Deficient cerebellar long-term depression impaired eyeblink conditioning and normal motor coordination in GFAP mutant mice. Neuron. 16:587–599. 1996. View Article : Google Scholar : PubMed/NCBI

16. 

Liedtke W, Edelmann W, Bieri PL, et al: GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron. 17:607–615. 1996. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

January-February 2011
Volume 2 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sugaya-Fukasawa M, Watanabe T, Tamura , Egashira S and Hisatomi H: Glial fibrillary acidic protein is one of the key factors underlying neuron-like elongation in PC12 cells. Exp Ther Med 2: 85-87, 2011.
APA
Sugaya-Fukasawa, M., Watanabe, T., Tamura, ., Egashira, S., & Hisatomi, H. (2011). Glial fibrillary acidic protein is one of the key factors underlying neuron-like elongation in PC12 cells. Experimental and Therapeutic Medicine, 2, 85-87. https://doi.org/10.3892/etm.2010.162
MLA
Sugaya-Fukasawa, M., Watanabe, T., Tamura, ., Egashira, S., Hisatomi, H."Glial fibrillary acidic protein is one of the key factors underlying neuron-like elongation in PC12 cells". Experimental and Therapeutic Medicine 2.1 (2011): 85-87.
Chicago
Sugaya-Fukasawa, M., Watanabe, T., Tamura, ., Egashira, S., Hisatomi, H."Glial fibrillary acidic protein is one of the key factors underlying neuron-like elongation in PC12 cells". Experimental and Therapeutic Medicine 2, no. 1 (2011): 85-87. https://doi.org/10.3892/etm.2010.162